Lanova Medicines Limited

This is the first human study of an experimental drug called LM-24C5 for people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how the body handles the drug. Researchers will also look for early signs…

This is the first study in people testing a new drug called LM-350 for advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how the body handles the drug. Researchers will also check for early signs that the dru…

This study is testing whether a new drug called LM-24C5, when combined with other cancer treatments, is safe and effective for people with advanced solid tumors that have a specific marker called CEACAM5. It will enroll about 130 adults whose cancer has returned or hasn't respond…

This study is testing a new drug called LM-2417 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see how well the body handles the drug, both alone and when combined with other cancer therapies. Resear…

This early-stage study is testing a new drug called LM-168, both alone and combined with an existing immunotherapy drug (toripalimab), in people with advanced solid tumors that have stopped responding to standard treatments. The first phase checks for safety and determines the ri…